Overview

Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
This randomised controlled trial aimed to verify whether directly observed single dose treatment (with tinidazole+fluconazole) would be as effective as the longer standard treatments (metronidazole for 7 days, plus vaginal clotrimazole for 3 days) in the syndromic management of women presenting with vaginal discharge in primary health care centers of Ghana, Togo, Guinea and Mali. It was designed as an effectiveness trial, i.e. it was done under conditions typical of routine work in these health centers
Phase:
Phase 3
Details
Lead Sponsor:
Université de Sherbrooke
Collaborator:
Canadian International Development Agency
Treatments:
Clotrimazole
Fluconazole
Metronidazole
Miconazole
Tinidazole